Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in tra...

Robak Tadeusz, Jin Jie, Pylypenko Halyna, Verhoef Gregor, Siritanaratkul Noppadol, Drach Johannes, Raderer Markus, Mayer Jiri, Pereira Juliana, Tumyan Gayane, Okamoto Rumiko, Demeter Judit, Egyed Miklós, Borbényi Zita, et al
2018